Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2020-09-28 | Amended | $2,800,000 | $1,450,001 | Equity Only | 06b | SEC link |
| 2019-12-02 | New | $1,349,999 | $1,349,999 | Equity Only | 06b | SEC link |
| 2019-07-09 | Amended | $3,193,548 | $1,511,550 | Equity Only | 06b | SEC link |
| 2018-04-09 | New | $1,681,998 | $1,681,998 | Equity Only | 06b | SEC link |
| 2017-12-29 | New | $425,000 | $425,000 | Equity Only | 06b | SEC link |
| 2010-04-14 | New | $757,971 | $757,971 | Debt Only | 06 | SEC link |
| Name | Role |
|---|---|
| Amanda Hayward | Director, Executive, Promoter |
| Jane Henderson | Executive |
| Gregory Ho | Director |
| Scheer Investment Holdings X, Llc | Promoter |
| George Maynard | Executive |
| Sylvia Mc Brinn | Director, Executive, Promoter |
| John Puziss | Director |
| David I. Scheer | Director, Promoter |
| Erika Smith | Director, Executive |
| Stephen Strittmatter | Promoter |
| David Wurzer | Director |